Teprotumumab for non-inflammatory thyroid eye disease (TED): evidence for increased IGF-1R expression-Reference-Cited by-同舟云学术

Teprotumumab for non-inflammatory thyroid eye disease (TED): evidence for increased IGF-1R expression

Published:2020-11-21 Issue:9 Volume:35 Page:2607-2612
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Ugradar Shoaib,Shi Lu^ORCID,Wang Yao,Mester Tunde,Yang Huasheng^ORCID,Douglas Raymond S.

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://www.nature.com/articles/s41433-020-01297-w.pdf

Reference14 articles.

1. Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362:726–38.

2. Ugradar S, Rootman DB. Case Series. Ophthal Plast Reconstr Surg 2018:1. http://insights.ovid.com/crossref?an=00002341-900000000-98532. Accessed 27 Mar 2018.

3. Mourits MP, Koornneef L, Wiersinga WM, et al. Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach. Br J Ophthalmol. 1989;73:639–44.

4. Kim JW, Woo YJ, Yoon JS. Is modified clinical activity score an accurate indicator of diplopia progression in Graves’ orbitopathy patients? Endocr J. 2016;63:1133–40. http://www.ncbi.nlm.nih.gov/pubmed/27628269. Accessed 5 Jan 2018.

5. Ugradar S, Rootman DB Case Series. Ophthal Plast Reconstr Surg 2018:1. http://www.ncbi.nlm.nih.gov/pubmed/29465483. Accessed 28 Feb 2018.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Teprotumumab for thyroid eye disease in patients with hypothyroid/euthyroid state: a multicenter case series;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-08-13

2. The Rate of Re-treatment in Patients Treated with Teprotumumab;Ophthalmology;2024-07

3. Teprotumumab for the Treatment of Thyroid Eye Disease;Endocrine Reviews;2024-06-05

4. A Novel Association Between Human Papillomavirus and Thyroid Eye Disease;2024-04-30

5. Teprotumumab improves light sensitivity in patients with thyroid eye disease;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-04-19